Inhibitory effects of autolysate of Leuconostoc mesenteroides isolated from kimoto on melanogenesis

J Biosci Bioeng. 2012 Oct;114(4):424-8. doi: 10.1016/j.jbiosc.2012.05.016. Epub 2012 Aug 18.

Abstract

We investigated the inhibitory effects of the autolysate of Leuconostoc mesenteroides, a lactic acid bacterium isolated from sake mash, on melanogenesis in B16F0 murine melanoma cells and a human skin model. The autolysate: induced a decrease in melanin content in B16F0 murine melanoma cells and a 17%, 36%, 41% and 58% decrease in the human skin model by the application of 0.125, 1.25, 6.25, and 12.5 mg/tissue in total; decreased tyrosinase activity to 71%, 46% and 29% of control in B16F0 cells with 0.1, 0.2 and 0.4 mg/ml-medium respectively, but did not inhibit tyrosinase activity under cell-free conditions; decreased amount of tyrosinase in a dose-dependent manner from 74% with 0.1 mg/ml to 33% with 0.4 mg/ml; and decreased amount of tyrosinase mRNA to 80-90% with 0.2-0.4 mg/ml-medium. As the decrease in tyrosinase mRNA levels could not fully account for the reduction in protein, we suggest that the autolysate had post-transcriptional effects rather than transcription inhibition. Our results indicate that the autolysate of L. mesenteroides has potential therapeutic use as an effective anti-melanogenic agent.

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Humans
  • In Vitro Techniques
  • Leuconostoc / chemistry*
  • Leuconostoc / metabolism
  • Melanins / metabolism*
  • Melanoma / drug therapy
  • Mice
  • Monophenol Monooxygenase / antagonists & inhibitors*
  • Monophenol Monooxygenase / genetics
  • Monophenol Monooxygenase / metabolism
  • Skin / drug effects*
  • Skin / metabolism
  • Skin Neoplasms / drug therapy

Substances

  • Antineoplastic Agents
  • Melanins
  • Monophenol Monooxygenase